Pemetrexed has been shown to improve survival rates and quality of life for patients with certain types of cancer. It is particularly effective when used in combination with other chemotherapy drugs or as part of a multimodal treatment approach, including surgery and radiation therapy. By targeting the folate pathway, pemetrexed offers a unique mechanism of action that can be effective even in cases where other treatments have failed.
